We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Northeast General Pharmaceutical Factory, an active pharmaceutical ingredient (API) supplier based in China, failed to conduct stability tests at scheduled intervals and did not appropriately maintain its equipment and facilities to prevent product contamination, according to an Oct. 31 warning letter.